Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Authors
Keywords
-
Journal
Pharmaceutics
Volume 12, Issue 1, Pages 29
Publisher
MDPI AG
Online
2020-01-04
DOI
10.3390/pharmaceutics12010029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Solid nanoparticles for oral antimicrobial drug delivery: a review
- (2019) Aun Raza et al. DRUG DISCOVERY TODAY
- A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
- (2019) Ermias Diro et al. PLoS Neglected Tropical Diseases
- The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
- (2019) Grace Cuddihy et al. Pharmaceutics
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- (2019) Xuemei Ge et al. Pharmaceutics
- Formulation and Characterization of a Self-nanoemulsifying Drug Delivery System of Amphotericin B for the Treatment of Leishmaniasis
- (2019) Momin Khan et al. IET Nanobiotechnology
- Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC)
- (2019) Janet Tan Sui Ling et al. AAPS PHARMSCITECH
- Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
- (2019) Andreas H Groll et al. CLINICAL INFECTIOUS DISEASES
- Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
- (2019) Jill Adler-Moore et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
- (2019) R. Lu et al. mBio
- Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
- (2019) Ruwandi Kariyawasam et al. BMC INFECTIOUS DISEASES
- Nanocapsules of Sterculia striata acetylated polysaccharide as a potential monomeric amphotericin B delivery matrix
- (2019) Fernanda Matoso Sombra et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Critical process parameters in manufacturing of liposomal formulations of amphotericin B
- (2019) Benjamin Rivnay et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models
- (2019) Faisal Usman et al. Drug Delivery and Translational Research
- Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases
- (2019) Juliane S. Lanza et al. Expert Opinion on Drug Delivery
- Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach
- (2019) Kaushik Thanki et al. MOLECULAR PHARMACEUTICS
- Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement
- (2018) Sanyog Jain et al. AAPS PHARMSCITECH
- Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier
- (2018) Faisal Usman et al. AAPS PHARMSCITECH
- Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis
- (2018) Ritam Sidhu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations
- (2018) Eden C. Andrew et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post–Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh
- (2018) Margriet den Boer et al. CLINICAL INFECTIOUS DISEASES
- Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies
- (2018) C. Rodrigo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dual alginate-lipid nanocarriers as oral delivery systems for amphotericin B
- (2018) Juliana Perdiz Senna et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B
- (2018) Kaushik Thanki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs
- (2018) Andrew Otte et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and in vitro evaluation of cost effective amphotericin B polymeric emulsion
- (2018) Zo-Ain Ishaq et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections
- (2018) Helena Hiemisch Lobo Borba et al. MYCOSES
- Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs
- (2018) J. Nieto et al. RESEARCH IN VETERINARY SCIENCE
- The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles
- (2018) Louise Walker et al. mBio
- Searching for a change: The need for increased support for public health and research on fungal diseases
- (2018) Marcio L. Rodrigues et al. PLoS Neglected Tropical Diseases
- Safety and Efficacy of High-Dose Infusions of a Preformed Amphotericin B Fat Emulsion for Treatment of Indian Visceral Leishmaniasis
- (2018) S. Sundar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method
- (2018) Yixian Zhou et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion
- (2018) Andreza Rochelle do Vale Morais et al. EXPERIMENTAL PARASITOLOGY
- Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection
- (2018) Koichi Fujimoto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Mechanism of Binding of Antifungal Antibiotic Amphotericin B to Lipid Membranes: An Insight from Combined Single-Membrane Imaging, Microspectroscopy, and Molecular Dynamics
- (2018) Ewa Grela et al. MOLECULAR PHARMACEUTICS
- Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B
- (2018) Janet Sui Ling Tan et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Imaging of human cells exposed to an antifungal antibiotic amphotericin B reveals the mechanisms associated with the drug toxicity and cell defence
- (2018) Ewa Grela et al. Scientific Reports
- A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
- (2018) Liliana López et al. PLoS Neglected Tropical Diseases
- Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release
- (2018) Aldemar Gordillo-Galeano et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome
- (2018) Jie Tang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanostructured lipid carriers containing Amphotericin B: Development, in vitro release assay, and storage stability
- (2018) Rosilene Rodrigues Santiago et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins
- (2018) Carmen López-Castillo et al. MOLECULES
- Fungal persister cells: The basis for recalcitrant infections?
- (2018) Jurgen Wuyts et al. PLoS Pathogens
- Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
- (2018) Vijay Mishra et al. Pharmaceutics
- Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B
- (2018) Zhimei Song et al. CARBOHYDRATE POLYMERS
- ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans
- (2017) José P. Guirao-Abad et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Correlating gastric emptying of amphotericin B and paracetamol solid lipid nanoparticles with changes in particle surface chemistry
- (2017) Hilda Amekyeh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Multi-Phase Solvation Model for Biological Membranes: Molecular Action Mechanism of Amphotericin B
- (2017) J. M. Falcón-González et al. Journal of Chemical Theory and Computation
- Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
- (2017) Fernanda S. Tonin et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Neglected endemic mycoses
- (2017) Flavio Queiroz-Telles et al. LANCET INFECTIOUS DISEASES
- Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis
- (2017) Lilian Sosa et al. Nanomedicine-Nanotechnology Biology and Medicine
- New perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: A mechanistic and histopathological investigation
- (2017) Afzal Hussain et al. Nanomedicine-Nanotechnology Biology and Medicine
- Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
- (2017) Ridwanur Rahman et al. PLoS Neglected Tropical Diseases
- Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
- (2017) Anuradha Chowdhary et al. PLoS Pathogens
- Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B
- (2017) Md. Shadab et al. PLoS One
- Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis
- (2016) Shilpa N. Patere et al. AAPS PHARMSCITECH
- Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species
- (2016) Abdullah M. S. Al-Hatmi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro
- (2016) Ana Paula Perez et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Topical Amphotericin B solid lipid nanoparticles: Design and development
- (2016) Dhruv Butani et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Exploring The Role Of Nanoparticles In Amphotericin B Delivery
- (2016) Soraia Zaioncz et al. CURRENT PHARMACEUTICAL DESIGN
- Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
- (2016) Qamar Zia et al. CURRENT PHARMACEUTICAL DESIGN
- Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B
- (2016) Afzal Hussain et al. DRUG DELIVERY
- Nosocomial Fungal Infections
- (2016) Geehan Suleyman et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antifungal Agents
- (2016) Jeniel E. Nett et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- The Global Burden of Fungal Diseases
- (2016) Snigdha Vallabhaneni et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii
- (2016) A. Batista-Duharte et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chitosan/ Sterculia striata polysaccharides nanocomplex as a potential chloroquine drug release device
- (2016) Guilherme A. Magalhães Jr. et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B
- (2016) Cláudia Serafim et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy
- (2016) Tian Fu et al. JOURNAL OF LIPOSOME RESEARCH
- Membrane Sterols Modulate the Binding Mode of Amphotericin B without Affecting Its Affinity for a Lipid Bilayer
- (2016) Anna Neumann et al. LANGMUIR
- Comparison between liposomal formulations of amphotericin B
- (2016) Jill P Adler-Moore et al. MEDICAL MYCOLOGY
- The fungicidal activity of amphotericin B requires autophagy-dependent targeting to the vacuole under a nutrient-starved condition in Saccharomyces cerevisiae
- (2016) Michiru Yoshioka et al. MICROBIOLOGY-SGM
- Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
- (2016) Laiza M. Steimbach et al. MYCOSES
- Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B
- (2016) Celeste Alvarez et al. PHARMACEUTICAL RESEARCH
- Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth
- (2016) Farazul Haque et al. Scientific Reports
- Molecular organization, localization and orientation of antifungal antibiotic amphotericin B in a single lipid bilayer
- (2016) Wojciech Grudzinski et al. Scientific Reports
- Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats
- (2015) Hilda Amekyeh et al. AAPS PHARMSCITECH
- A Gastrointestinal Transit Study on Amphotericin B-Loaded Solid Lipid Nanoparticles in Rats
- (2015) Hilda Amekyeh et al. AAPS PHARMSCITECH
- Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation
- (2015) Kajiram Adhikari et al. AAPS PHARMSCITECH
- In VitroActivities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates
- (2015) Anuradha Chowdhary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Taming Amphotericin B
- (2015) Vaclav Janout et al. BIOCONJUGATE CHEMISTRY
- Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
- (2015) Mohammad Asad et al. BMC INFECTIOUS DISEASES
- Solubilization power of an amino acid-based gemini surfactant towards the hydrophobic drug amphotericin B
- (2015) Célia Faustino et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Candida tropicalis biofilm's matrix—involvement on its resistance to amphotericin B
- (2015) Tânia Fernandes et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A new look at the antibiotic amphotericin B effect on Candida albicans plasma membrane permeability and cell viability functions
- (2015) Barbara Chudzik et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Nanoemulsions loaded with amphotericin B: A new approach for the treatment of leishmaniasis
- (2015) Leila Rodrigues Caldeira et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Th-1 biased immunomodulation and synergistic antileishmanial activity of stable cationic lipid–polymer hybrid nanoparticle: Biodistribution and toxicity assessment of encapsulated amphotericin B
- (2015) Shalini Asthana et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application
- (2015) Yashpal S. Chhonker et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles
- (2015) Ming-Thau Sheu et al. International Journal of Nanomedicine
- Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections
- (2015) Ana C. Moreno-Rodríguez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms
- (2015) Akira Kawai et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Neutron Scattering Studies of the Effects of Formulating Amphotericin B with Cholesteryl Sulfate on the Drug’s Interactions with Phospholipid and Phospholipid–Sterol Membranes
- (2015) F. Foglia et al. LANGMUIR
- Antifungal antibiotics modulate the pro-inflammatory cytokine production and phagocytic activity of human monocytes in an in vitro sepsis model
- (2015) Stefan Muenster et al. LIFE SCIENCES
- Development and characterization of oral liposomes of vegetal ceramide based amphotericin B having enhanced dry solubility and solubility
- (2015) Malika Skiba-Lahiani et al. Materials Science & Engineering C-Materials for Biological Applications
- Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles
- (2015) Dolores R. Serrano et al. MOLECULAR PHARMACEUTICS
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation
- (2015) Maddalena Peghin et al. TRANSPLANT INTERNATIONAL
- Development and Characterization of Spray Dried Microparticles for Pulmonary Delivery of Antifungal Drug
- (2015) Divita Mathpal et al. Current Drug Delivery
- Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module
- (2015) Manisha B. Chaudhari et al. Drug Delivery and Translational Research
- The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
- (2014) Ana Cecilia Mesa-Arango et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-term sustained-releasedin situgels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation,in vitroandin vivoevaluation
- (2014) Guo Shan-Bin et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B
- (2014) Afzal Hussain et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature
- (2014) Kishor M. Wasan et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
- (2014) Daniel Michał Kamiński EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection
- (2014) Ping Xu et al. International Journal of Nanomedicine
- Study of amphotericin B magnetic liposomes for brain targeting
- (2014) Mengyu Zhao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation
- (2014) Katkam N. Gangadhar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanoethosomal formulation for skin targeting of amphotericin B: anin vitroandin vivoassessment
- (2014) Lakhvir Kaur et al. JOURNAL OF LIPOSOME RESEARCH
- In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
- (2014) M. T. Montagna et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Self-Association of Amphotericin B: Spontaneous Formation of Molecular Structures Responsible for the Toxic Side Effects of the Antibiotic
- (2014) Joanna Starzyk et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice
- (2014) J. A. Olson et al. MEDICAL MYCOLOGY
- Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method
- (2014) F. D. Rojas et al. MEDICAL MYCOLOGY
- Amphotericin forms an extramembranous and fungicidal sterol sponge
- (2014) Thomas M Anderson et al. Nature Chemical Biology
- Fungal Biofilms, Drug Resistance, and Recurrent Infection
- (2014) J. V. Desai et al. Cold Spring Harbor Perspectives in Medicine
- Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
- (2014) Shyam Sundar et al. PLoS Neglected Tropical Diseases
- Properties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee’S Wax
- (2014) Chloe Tan et al. Nanomaterials
- Antifungal Lock Therapy With Liposomal Amphotericin B: A Prospective Trial
- (2014) William McGhee et al. Journal of the Pediatric Infectious Diseases Society
- Lipid Effects on Expulsion Rate of Amphotericin B from Solid Lipid Nanoparticles
- (2013) See Wei Tan et al. AAPS PHARMSCITECH
- Niosomes from 80s to present: The state of the art
- (2013) Carlotta Marianecci et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Successful Treatment of Pulmonary Blastomycosis with Continuously Infused Amphotericin B Deoxycholate After Failure with Liposomal Amphotericin B
- (2013) Robert E Ariano et al. ANNALS OF PHARMACOTHERAPY
- New Insight into Amphotericin B Resistance in Aspergillus terreus
- (2013) Gerhard Blum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
- (2013) Angela S Loo et al. Expert Opinion On Drug Safety
- NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency
- (2013) Michael Oda et al. International Journal of Nanomedicine
- An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity
- (2013) L. Y. A. Chai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Alteration in cellular viability, pro-inflammatory cytokines and nitric oxide production in nephrotoxicity generation by Amphotericin B: involvement of PKA pathway signaling
- (2013) F. D. França et al. JOURNAL OF APPLIED TOXICOLOGY
- Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
- (2013) Victor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis
- (2013) Fady Ibrahim et al. Lipids in Health and Disease
- Development of Amphotericin B-Loaded Cubosomes Through the SolEmuls Technology for Enhancing the Oral Bioavailability
- (2012) Zhiwen Yang et al. AAPS PHARMSCITECH
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics of Amphotericin B Colloidal Dispersion in Critically Ill Patients with Cholestatic Liver Disease
- (2012) Stefan Weiler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacious Treatment of Non-Dermatophyte Mould Onychomycosis with Topical Amphotericin B
- (2012) Massimo Lurati et al. DERMATOLOGY
- Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model
- (2012) Fady Ibrahim et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis
- (2012) Alexandra F. Gazzoni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- How can micelle systems be rebuilt by a heating process?
- (2012) Eryvaldo Egito et al. International Journal of Nanomedicine
- Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis
- (2012) W. R. Kirkpatrick et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin B-Loaded Nanocarriers for Topical Treatment of Cutaneous Leishmaniasis: Development, Characterization, and In Vitro Skin Permeation Studies
- (2012) Journal of Biomedical Nanotechnology
- The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection
- (2012) M. Alsaadi et al. JOURNAL OF CONTROLLED RELEASE
- Toward Understanding of Toxic Side Effects of a Polyene Antibiotic Amphotericin B: Fluorescence Spectroscopy Reveals Widespread Formation of the Specific Supramolecular Structures of the Drug
- (2012) Piotr Wasko et al. MOLECULAR PHARMACEUTICS
- Amphotericin primarily kills yeast by simply binding ergosterol
- (2012) K. C. Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
- (2012) Ana C. Mesa-Arango et al. Frontiers in Microbiology
- A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis
- (2011) Amitabha Chattopadhyay et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine liposome-intercalated amphotericin B
- (2011) Maryam Iman et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- AmbiOnp: Solid Lipid Nanoparticles of Amphotericin B for Oral Administration
- (2011) Pratikkumar A. Patel et al. Journal of Biomedical Nanotechnology
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model
- (2011) Olena Sivak et al. Lipids in Health and Disease
- In vitro activity of amphotericin B cochleates against Leishmania chagasi
- (2011) Aretha Molina Sesana et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst
- (2011) Fernanda Sangalli-Leite et al. MICROBES AND INFECTION
- A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14 -Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
- (2010) C. M. Martel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nanosomal Amphotericin B is an efficacious alternative to Ambisome® for fungal therapy
- (2010) Saifuddin Sheikh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel
- (2010) June-Woo Kang et al. JOURNAL OF DRUG TARGETING
- Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogenTrichosporonisolated from Turkish patients
- (2010) Ayse Kalkanci et al. MEDICAL MYCOLOGY
- Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients
- (2010) Shahid Husain et al. TRANSPLANTATION
- A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model
- (2010) Ellen K. Wasan et al. PLoS Neglected Tropical Diseases
- Amphotericin B-Induced Renal Tubular Cell Injury Is Mediated by Na+ Influx through Ion-Permeable Pores and Subsequent Activation of Mitogen-Activated Protein Kinases and Elevation of Intracellular Ca2+ Concentration
- (2009) T. Yano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of antifungals against Zygomycetes
- (2009) A. Alastruey-Izquierdo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Differences in human phospholipid transfer protein activity following incubation of Fungizone® compared to lipid-based Amphotericin-B formulations in normolipidemic and hyperlipidemic plasma
- (2009) Ryan J. Henderson et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans
- (2009) Ellen K. Wasan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
- (2009) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii
- (2009) C. Pereira Silveira et al. JOURNAL OF MEDICAL MICROBIOLOGY
- On the Possibility of the Amphotericin B-Sterol Complex Formation in Cholesterol- and Ergosterol-Containing Lipid Bilayers: A Molecular Dynamics Study
- (2009) Anna Neumann et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Treatment of Central Venous Catheter Fungal Infection Using Liposomal Amphotericin-B Lock Therapy
- (2009) Bradley S. Buckler et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Amphotericin B: side effects and toxicity
- (2009) Rafael Laniado-Laborín et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Complex Formation of Amphotericin B in Sterol-Containing Membranes As Evidenced by Surface Plasmon Resonance†
- (2008) Ryota Mouri et al. BIOCHEMISTRY
- Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
- (2008) Bart J. Rijnders et al. CLINICAL INFECTIOUS DISEASES
- In vitro susceptibility of Cryptococcus gattii clinical isolates
- (2008) A. Gomez-Lopez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms
- (2008) Pranab K. Mukherjee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of aggregation state on the toxicity of different amphotericin B preparations
- (2008) Raquel Espada et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC®: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry
- (2008) David L. Paterson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin B Formulations and Drug Targeting
- (2007) J.J. Torrado et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of Cholesterol on the Release of Amphotericin B from PEG-Phospholipid Micelles
- (2007) Ronak Vakil et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation